Cleveland HeartLab, Inc. is a leading provider of diagnostic services specializing in cardiometabolic disorders. As the base for Quest's first national center of excellence in this field, Cleveland HeartLab offers innovative blood and urine biomarkers that provide a comprehensive assessment of cardiovascular risk. Their collaboration with Cleveland Clinic allows them to offer diagnostic services based on cutting-edge research in inflammation and other areas of medicine.
With a focus on innovation, education, and clinical references, Cleveland HeartLab is committed to advancing the understanding and identification of cardiovascular risk. Their research and development program, in partnership with renowned academic and medical institutions, brings unique biomarker technologies to the market. By measuring inflammation levels and utilizing a multi-marker approach, they aim to uncover hidden risks that may be missed by standard lipid testing, ultimately helping patients and physicians nationwide in the prevention and management of heart disease.
Generated from the website